PE Deals

Showing its conviction around the future growth potential of the behavioral health company, TPG underwrote the deal in all equity in the midst of a downturn.

The deal highlights the fact that PIPE investors in a SPAC are underwriting to different financial metrics than prospective PE buyers – leading to much larger valuations in some cases.

This theme is being embraced by investors across the spectrum and could be a boon for payors, providers and, most importantly, patients.

The deal also included a commitment by the joint venture of up to $250 million in new preferred equity capital over the next 18 months.

Both large private equity firms and strategics are expected to be in the mix, sources said.

Madison Dearborn Partners, which is out fundraising for its seventh pool, is expected to quadruple its investment with the sale of Sage Products. Stryker Corp said Monday it would buy Sage for $2.7 billion cash. The deal is expected to close in second quarter. Cary, Illinois-based Sage makes disposable medical supplies that are used to […]

Pamplona formed nThrive in 2015 when it married MedAsset's revenue cycle management business with existing platform Precyse.

NaviHealth, which aims to reduce the cost of post-acute healthcare, trades hands yet again in a deal valued around $2.5 billion including debt, according to sources. 

PeHUB gets a guest blogger in private equity group pro Matt Stewart at Fenwick & West, who says growth equity transactions are blurring the lines between PE & VC--but in a good way.

As JAB Investors reportedly readies to take National Veterinary Associates public, it writes yet another large check to grow its specialty vet business.